| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |